A Final Note & Gentle PSA on the GLP-1 Pipeline On the topic of GLP-1 misinformation, I'd like to share something from a webinar that really irked me, particularly in terms of the direction this GLP-1 marketing blitz is headed
David Nazarian and the My Concierge MD team welcome consultations for peptide therapy from patients throughout Beverly Hills and greater Los Angeles, with house call and hotel visit options for patients who prefer care at their location
An insulin syringe provides fine, precise volume markings that make it easier to draw an exact amount of bacteriostatic water or reconstituted solution, which matters for maintaining a consistent, known concentration across a research protocol
PMID: 30069296 7 Molecular Autopsy Implicates Primary Carnitine Deficiency in Sudden Unexplained Death and Reversible Short QT Syndrome
doi:10.1002/14651858.CD001838.pub6
Starting cagrilintide when already on retatrutide If you are already established on retatrutide at a stable dose (meaning you have been at your current retatrutide dose for at least four weeks without significant GI issues), you can introduce cagrilintide at its lowest starting dose of 0.25 mg weekly